Shares of Volatus Aerospace fell 12.3% to $0.50 after the Canadian drone company reported second-quarter results that badly missed expectations, raising pointed questions about whether its pivot toward defence revenue is progressing fast enough to justify investor faith. Volatus Aerospace's Defence Dream Hits a Supply-Chain Wall — Is $59 Million in Cash Enough to Keep Investors On Board?
Shares of Volatus Aerospace (TSX: FLT) dropped 12.3% to $0.50 Thursday after the Canadian drone-and-defence company delivered a quarter that punched well below its weight. Revenue came in at $8.42 million, down from $10.59 million a year ago , landing roughly 25.7% below what analysts expected. The miss revives a central worry: this company's growth story depends on lumpy government contracts that can slip without warning.
• A Single Delayed Contract Wiped Out the Growth Narrative. Management blamed the shortfall on one defence contract worth about $2.6 million whose delivery wasn't completed in the quarter because of supply-chain disruption.
Excluding that contract, the rest of the business grew modestly year over year — but "modestly" doesn't cut it when the stock had rallied on the premise that NATO-aligned drone orders would accelerate. Back in December 2025, Volatus won a contract valued at up to CA$9 million from a NATO partner, with an initial $4.5 million tranche due in Q1 2026. Repeated slippage signals that translating pipeline into revenue remains the company's Achilles' heel.
• Margins Shrank Even as the Company Spent More. Gross margin softened to 29.3% from 31.9% a year ago, weighted down by a heavier defence product mix, while adjusted EBITDA stayed negative as operating expenses rose. The widening EBITDA loss to $(4.35) million tells shareholders that Volatus is burning more cash to build capacity — including a new 53,000-square-foot manufacturing facility at Montreal's Mirabel airport opened in June — without the revenue to match.
• A Record Cash Pile Buys Time, Not Confidence. Volatus exited Q2 with a record $59.2 million in cash and $63.8 million in working capital, reflecting its strongest liquidity to date. That runway is real and removes any near-term survival risk. But cash on the balance sheet is a shield, not a sword — it reassures creditors, not growth investors who need to see revenue climb toward the CA$13–17 million quarterly range analysts consider necessary for the company to approach breakeven.
• The Earnings Call Today Is a Make-or-Break Moment. Management hosts its Q2 call this morning at 8:30 a.m. ET. Investors will listen for one thing above all: a firm timeline for recognizing the delayed $2.6 million contract. If the revenue is simply pushed to Q3, the selloff may prove overdone. If supply-chain problems persist, the stock's recent run from $0.51 to $0.57 before earnings could fully unwind — and then some.